[ad_1] NEW YORK, Oct. 28, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, […]
Tag: THE ROSEN LAW FIRM
MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Oct. 28, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, […]
SINA Investors Have Opportunity to Lead Sina Corporation Securities Fraud Lawsuit
[ad_1] NEW YORK, Oct. 28, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds sellers of ordinary shares, including those that sold into the Merger of Sina Corporation (NASDAQ: SINA) […]
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation
[ad_1] NEW YORK, Oct. 27, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR). […]
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Oct. 27, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, […]
